Current Protein and Peptide Science - Volume 19, Issue 5, 2018

Background: Sphingosine kinase 1 (SK1) overexpression and elevated sphingosine-1-phosphate (S1P) levels have been correlated with many disease states from cancer to inflammatory diseases to diabetes. Even though SK1 inhibitors are of consideberable interest as effective chemotherapeutic agents, poor potency, lack of selectivity and poor pharmacokinetic properties have been major problems in the first Read More

Background: Identification of interaction between drugs and target proteins plays an important role in discovering new drug candidates. However, through the experimental method to identify the drug-target interactions remain to be extremely time-consuming, expensive and challenging even nowadays. Therefore, it is urgent to develop new computational methods to predict potential drugtarget interactions (DTI). Methods: In t Read More

Background: Inferring drug-target interaction (DTI) candidates for new drugs or targets without any interaction information is a critical challenge for modern drug design and discovery. Results from existing DTI inference methods indicate that these approaches necessitate further improvement. Methods: In this paper, we developed a novel DTI identification model (PreNNDS) by integrating Neighbor interaction profi Read More

Background: Drug-Target Interactions (DTI) play a crucial role in discovering new drug candidates and finding new proteins to target for drug development. Although the number of detected DTI obtained by high-throughput techniques has been increasing, the number of known DTI is still limited. On the other hand, the experimental methods for detecting the interactions among drugs and proteins are costly and inefficient. Read More

Background: A basic task in drug discovery is to find new medication in the form of candidate compounds that act on a target protein. In other words, a drug has to interact with a target and such drug-target interaction (DTI) is not expected to be random. Significant and interesting patterns are expected to be hidden in them. If these patterns can be discovered, new drugs are expected to be more easily discoverable. Objecti Read More

Background: Experimental approaches to identify drug-target interactions (DTIs) among a large number of chemical compounds and proteins are still costly and time-consuming. As an assistant, computational approaches are able to rapidly infer potential drug or target candidates for diverse screenings on a large scale. The most difficult scenario (S4) of screenings tries to explore the pairwise interacting candidates between n Read More

Background: During the development process of new drugs, identification of the drug-target interactions wins primary concerns. However, the chemical or biological experiments bear the limitation in coverage as well as the huge cost of both time and money. Based on drug similarity and target similarity, chemogenomic methods can be able to predict potential drug-target interactions (DTIs) on a large scale and have no lu Read More

The mitochondrial carrier family (solute carrier family 25) is a super family of nuclearencoded transporters localized on the inner mitochondrial membranes. In human, the mitochondrial carrier family has 53 members, all with a ternary structure of six transmembrane α-helices. The structure of mitochondrial carrier family has three repeats of conservative motifs. The members of this family connect the inter membr Read More